Through the analysis of transgelin and its downstream target, tensin1, the mRNA and protein levels were found to be significantly increased in CRC patients; inhibition of transgelin or tensin1 reduced the proliferation and invasion of tumor cells. The gene discussed is TAGLN; the disease is colorectal carcinoma.